Cogent Biosciences (COGT) Interest & Investment Income (2017 - 2026)
Cogent Biosciences' (COGT) quarterly Interest & Investment Income came in at -$770000.0 in Q1 2026, down 126.08% year-on-year from $3.0 million in Q1 2025, and up 91.72% on a QoQ basis from -$9.3 million in Q4 2025.
Cogent Biosciences (COGT) Interest & Investment Income (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has 10 years of Interest & Investment Income data on file, last reported at -$770000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 126.08% year-over-year to -$770000.0 in Q1 2026; TTM through Mar 2026 was -$6.3 million, a 129.72% decrease from a year earlier, with the FY2025 full-year figure at -$92000.0, down 100.51% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$770000.0, up from -$9.3 million in the prior quarter.
- Over the last five years, Interest & Investment Income for COGT reached as high as $17.4 million in Q4 2024 and fell as low as -$9.3 million in Q4 2025.
- Historically, Interest & Investment Income has averaged $1.2 million across 5 years, with a median of $120000.0 in 2023.
- On a YoY basis, Interest & Investment Income climbed as much as 4071.77% in 2024 and fell as far as 337.5% in 2024.
- Year by year, Interest & Investment Income stood at $4.2 million in 2022, then slumped by 89.93% to $418000.0 in 2023, then surged by 4071.77% to $17.4 million in 2024, then sank by 153.35% to -$9.3 million in 2025, then surged by 91.72% to -$770000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$770000.0 in Q1 2026, -$9.3 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Cogent Biosciences | 6.57 Bn | 6.57 Bn | - | -770,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -770,000.00 |
| Dec 31, 2025 | -9.30 Mn |
| Sep 30, 2025 | 3.89 Mn |
| Jun 30, 2025 | -151,000.00 |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 17.44 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | -153,000.00 |
| Mar 31, 2024 | -285,000.00 |
| Dec 31, 2023 | 418,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -113,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 272,000.00 |
| Mar 31, 2022 | 107,000.00 |
| Dec 31, 2021 | -360,000.00 |
| Sep 30, 2021 | 115,000.00 |
| Jun 30, 2021 | 120,000.00 |